Trial Profile
Study comparing the safety and efficacy of abatacept, in rheumatoid arthritis patients who failed to prior biologics treatment (switch group ) and biologic naïve group
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 03 Aug 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.